Abstract

Reaction of blue crystalline solid trans-[CuCl2(4-Clpy)2] 1 (4-Clpy = 4-chloropyridine) with anhydrous HCl gas yields yellow crystalline salt (4-ClpyH)2[CuCl4] 2 with quantitative conversion. The reaction has been followed in situ by synchrotron powder X-ray diffraction using a specially designed gas-handling rig and demonstrates that the initial product is a C-centred monoclinic form of (4-ClpyH)2[CuCl4] (phase II), which then converts in the solid state to a primitive monoclinic form (phase I). The conversion has been quantified at each stage by mixed-phase Rietveld refinement of the powder diffraction data. The two polymorphic forms exhibit different patterns of N–H⋯Cl(Cu) hydrogen bonding and C–Cl⋯Cl(Cu) halogen bonding. Evidence from solution-phase crystallisations of 2 suggests that phase II is a kinetic product and phase I is the thermodynamic product. The salt 2 can also be prepared mechanochemically, by grinding for 2 min green-blue solid CuCl2·2H2O with white solid [4-ClpyH]Cl in a 1 : 2 stoichiometric ratio. The product was identified by powder diffraction as phase I of compound 2 in 97.5% yield, with the remaining material being compound 1.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.